Topic
Direct listings
4 articles

Direct listings
What City Therapeutics Got Right: A 2026 Listing Playbook for Smaller Issuers
Anchor investors first, float from the offering itself, pricing for the aftermarket, verifiable validation. Andy Altahawi on how the City Therapeutics IPO maps onto Reg A+, 506(b) and direct listing paths.

Guide
Benefits and risks of a direct listing, explained
What a direct listing offers and what it costs: liquidity, fees, price discovery, volatility, disclosure duties and the points issuers and investors weigh.

Guide
Direct listing requirements on Nasdaq and the NYSE
How Nasdaq and the NYSE test a company for a direct listing: market value of unrestricted shares, valuation evidence, price rules and where to check the rules.

Guide
Direct listing vs. IPO: going public without an IPO
A plain-English guide to how a direct listing differs from an IPO: who sells shares, what the SEC requires, how the opening auction works and when each fits.